|
DNAJB14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6525000035017E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.36079999952288E-07 |
| Normal-vs-Stage2 |
1.205850E-04 |
| Normal-vs-Stage3 |
3.43870000252267E-08 |
| Normal-vs-Stage4 |
9.20970000262145E-08 |
| Stage1-vs-Stage2 |
8.635800E-01 |
| Stage1-vs-Stage3 |
1.536390E-01 |
| Stage1-vs-Stage4 |
1.419020E-01 |
| Stage2-vs-Stage3 |
4.149600E-01 |
| Stage2-vs-Stage4 |
2.895000E-01 |
| Stage3-vs-Stage4 |
7.178400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.81729999937374E-08 |
| Normal-vs-AfricanAmerican |
1.046010E-02 |
| Normal-vs-Asian |
1.34249999994562E-06 |
| Caucasian-vs-AfricanAmerican |
2.863600E-01 |
| Caucasian-vs-Asian |
6.494600E-01 |
| AfricanAmerican-vs-Asian |
1.909240E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.10359993050247E-10 |
| Normal-vs-Female |
3.90189999976975E-07 |
| Male-vs-Female |
7.788300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.70196000000011E-05 |
| Normal-vs-Age(41-60Yrs) |
6.1167999998446E-08 |
| Normal-vs-Age(61-80Yrs) |
6.17140000214178E-08 |
| Normal-vs-Age(81-100Yrs) |
6.144400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.071200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.819360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.769400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.966200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.515600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.108000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.637640E-02 |
| Classical-VS-Follicular |
4.713800E-01 |
| Classical-VS-Other |
1.836170E-01 |
| Classical-VS-Normal |
8.33119999987808E-07 |
| Tall-VS-Follicular |
1.497990E-01 |
| Tall-VS-Other |
5.856400E-01 |
| Tall-VS-Normal |
4.39259999485131E-08 |
| Follicular-VS-Other |
3.222000E-01 |
| Follicular-VS-Normal |
1.71647999999136E-05 |
| Other-VS-Normal |
1.656680E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.16880000011754E-07 |
| Normal-vs-N1 |
1.20560000005376E-06 |
| N0-vs-N1 |
4.450400E-01 |
|
|
